|
Volumn , Issue , 2008, Pages 280-288
|
Prognosis and primary therapy in peripheral T-cell lymphomas.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANAPLASTIC LYMPHOMA KINASE;
ANTINEOPLASTIC AGENT;
CHOP PROTOCOL;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
PREDNISONE;
PROTEIN TYROSINE KINASE;
VINCRISTINE;
ARTICLE;
CHROMOSOME 2;
CHROMOSOME 5;
CLASSIFICATION;
CUTANEOUS T CELL LYMPHOMA;
GENE TRANSLOCATION;
GENETICS;
HUMAN;
IMMUNOLOGY;
LYMPH NODE;
MORTALITY;
NATURAL KILLER CELL;
NOSE TUMOR;
PATHOLOGY;
PERIPHERAL T CELL LYMPHOMA;
PROGNOSIS;
SURVIVAL RATE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHROMOSOMES, HUMAN, PAIR 2;
CHROMOSOMES, HUMAN, PAIR 5;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
HUMANS;
KILLER CELLS, NATURAL;
LYMPH NODES;
LYMPHOMA, T-CELL, CUTANEOUS;
LYMPHOMA, T-CELL, PERIPHERAL;
NOSE NEOPLASMS;
PREDNISONE;
PROGNOSIS;
PROTEIN-TYROSINE KINASES;
SURVIVAL RATE;
TRANSLOCATION, GENETIC;
VINCRISTINE;
|
EID: 67651171726
PISSN: 15204391
EISSN: None
Source Type: Journal
DOI: 10.1182/asheducation-2008.1.280 Document Type: Article |
Times cited : (41)
|
References (0)
|